Earnings Preview: Novavax to Report Financial Results Pre-market on November 12
$Novavax(NVAX.US)$ is scheduled to release its financial results pre-market on November 12 ET. Earnings PreviewAnalysts estimate $Novavax(NVAX.US)$ to post revenue of USD65.78M for 2024Q3, down 64.82%
Novavax has reached a settlement with the United Kingdom on terminating the supply of COVID-19 vaccines.
Epoch on November 6th | Vaccine manufacturer novavax has reached a termination and settlement agreement with the United Kingdom Health Security Agency (UKHSA) on the supply issues of its COVID-19 vaccine. Under the settlement agreement, the company will refund 0.1238 billion US dollars to health institutions over the course of three years.
Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?
Express News | Novavax Shares Fall 7.4% on Termination of UK Vaccine Supply Agreement
Express News | Pfizer Down 2.4%, Moderna Down 3%, Novavax Down 7.2%
Express News | Shares of Vaccine Makers Fall in Early Trading as Donald Trump Elected US President